Clinical Trials
29 trialsLow-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Sun Yat-sen University
CLEAR-03
Fudan University
TRIUNITE06
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
FUDOSE
UNICANCER
LDRT Combined With Immunochemotherapy for Colorectal Cancer With Liver Metastasis
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
First Affiliated Hospital of Zhejiang University
A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation
Harbin Medical University
AXOAXI
Helsinki University Central Hospital
CRC - PTX
Tanta University
IDEA
GERCOR - Multidisciplinary Oncology Cooperative Group
SIRTCI
Federation Francophone de Cancerologie Digestive
Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer
Fudan University
PARECEC
Peking University Cancer Hospital & Institute
Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer
Sun Yat-sen University
A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)
Merck Sharp & Dohme LLC
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)
Hoffmann-La Roche
XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
Harbin Medical University
XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
Harbin Medical University
HORIZON II
AstraZeneca
SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer
The First People's Hospital of Changzhou
Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy
Jiangsu Province Hospital of Traditional Chinese Medicine
ANGIOSWITCH
Grupo Hospital de Madrid
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Samsung Medical Center
Phase II Study of Bevacizumab, Capecitabine and Oxaliplatin in Colon Cancer
Asan Medical Center
Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer
Hallym University Medical Center
A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer.
Hoffmann-La Roche
Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
New Mexico Cancer Research Alliance
Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer
Royal Marsden NHS Foundation Trust
Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)
Guangdong Provincial People's Hospital